Skip to main content

Quest Diagnostics: Manuel Méndez

Quest Diagnostics has named Manuel Méndez its senior VP and chief commercial officer, effective Oct. 7. Méndez is leaving Qiagen, where he currently is senior VP, global commercial operations and a member of the executive committee. Prior to joining Qiagen, he was executive VP Americas for BioMérieux.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.